Xevant Recognized for Excellence and Thought Leadership at PBMI’s Annual National Conference
PBMI Excellence Award Winners Pictured left to right: Brandon Newman, Xevant; Jessica Ringena, Vivid Clear…
PBMI Excellence Award Winners Pictured left to right: Brandon Newman, Xevant; Jessica Ringena, Vivid Clear…
LONG BEACH, Calif.–(BUSINESS WIRE)–California Resources Corporation (NYSE: CRC) plans to release its third quarter 2023…
BIRMINGHAM, Ala.–(BUSINESS WIRE)–Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today announced that…
SAN FRANCISCO–(BUSINESS WIRE)–Planet Labs PBC (NYSE:PL), a leading provider of daily data and insights about…
SAN DIEGO & NEW YORK–(BUSINESS WIRE)–Teradata (NYSE: TDC) and ActionIQ announced today a new joint-offering…
Semtech joins the newly established non-profit organization Mobile Optical Pluggables Alliance (MOPA) Board of Directors…
AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine LOS ANGELES, Oct. 02,…
GUILFORD, Conn., Oct. 02, 2023 (GLOBE NEWSWIRE) — OrphAI Therapeutics Inc., a clinical-stage biopharmaceutical company…
Leading MDR technology responds to malicious events DENVER, Oct. 02, 2023 (GLOBE NEWSWIRE) — Pax8,…
CHICAGO, Oct. 02, 2023 (GLOBE NEWSWIRE) — Youtech, a full-service marketing agency, is pleased to…
Live-streamed Event will feature top developer productivity and experience leaders from GitLab, Microsoft, Nasdaq, and…
Toronto, Ontario–(Newsfile Corp. – October 2, 2023) – SATO Technologies Corp. (TSXV: SATO) (OTCQB: CCPUF)…
Collaboration delivers turnkey solution for N x 200G/lane market, paving the way to successful deployment…
Target applications include video security and surveillance, public safety, traffic management, retail loss prevention, manufacturing…
Continued collaboration accelerates 200G per lane deployment with advanced optics CAMARILLO, Calif.–(BUSINESS WIRE)–Semtech Corporation (Nasdaq:…
New datasets deliver insights into treatment effectiveness, patient subtypes, and patient outcomes for accelerating research…
804 Alzheimer’s Patients Are Enrolled in a Pivotal Phase 3 Clinical Trial A Second Pivotal…
GOLDEN, Colo., Oct. 02, 2023 (GLOBE NEWSWIRE) — In a bold move to democratize access…
804 Alzheimer’s Patients Are Enrolled in a Pivotal Phase 3 Clinical Trial A Second Pivotal…
– Bipartisan resolution highlights the challenges patients with rare cancers face and raises awareness and…